Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

Eisen, A; Somerfield, MR; Accordino, MK; Blanchette, PS; Clemons, MJ; Dhesy-Thind, S; Dillmon, MS; D'Oronzo, S; Fletcher, GG; Frank, ES; Hallmeyer, S; Makhoul, I; Moy, B; Thawer, A; Wu, JY; Van Poznak, CH

Somerfield, MR (通讯作者),Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (7):

Abstract

PURPOSE To update recommendations of the American Society of Clinical Oncology (ASCO)-Ontario Health (Cancer Care Ontario [CCO]) adjuvant bone-modifyi......

Full Text Link